Streamline Health Solutions (NASDAQ:STRM) Earns Sell Rating from Analysts at StockNews.com

Research analysts at StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research note issued on Sunday. The brokerage set a “sell” rating on the stock.

Separately, Craig Hallum upgraded shares of Streamline Health Solutions to a “strong-buy” rating in a report on Thursday, September 5th.

Streamline Health Solutions Price Performance

Shares of Streamline Health Solutions stock opened at $2.58 on Friday. The stock has a market capitalization of $10.90 million, a P/E ratio of -0.52 and a beta of 1.64. Streamline Health Solutions has a one year low of $1.85 and a one year high of $9.75. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.61 and a quick ratio of 0.61. The business’s 50 day simple moving average is $3.26 and its two-hundred day simple moving average is $5.51.

Streamline Health Solutions (NASDAQ:STRM) last posted its quarterly earnings results on Wednesday, September 11th. The company reported ($0.75) EPS for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.15). The firm had revenue of $4.48 million for the quarter. Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.